Migraine is frequent in children and adolescents with neurofibromatosis type 1

Background Despite the high prevalence of headache in patients with neurofibromatosis type 1 (NF1), little data exist regarding the classification and characterization of headaches experienced by these patients. This paper describes a study of headache in patients with NF1 compared with healthy cont...

Full description

Saved in:
Bibliographic Details
Published inPediatrics international Vol. 56; no. 6; pp. 865 - 867
Main Authors Pinho, Ricardo Silva, Fusão, Eduardo Ferracioli, Paschoal, Joelma Karina Sagica Fernandes, Caran, Eliana Maria Monteiro, Minett, Thaís Soares Cianciarullo, Vilanova, Luiz Celso Pereira, Masruha, Marcelo Rodrigues
Format Journal Article
LanguageEnglish
Published Australia Blackwell Publishing Ltd 01.12.2014
Subjects
Online AccessGet full text
ISSN1328-8067
1442-200X
1442-200X
DOI10.1111/ped.12375

Cover

Abstract Background Despite the high prevalence of headache in patients with neurofibromatosis type 1 (NF1), little data exist regarding the classification and characterization of headaches experienced by these patients. This paper describes a study of headache in patients with NF1 compared with healthy controls. Methods In this transversal study, participants (aged 4–19 years) were classified into two groups: NF1 patients or control subjects. The diagnosis of NF1 was performed according to the diagnostic criteria of the National Institutes of Health Consensus Conference, and the headache diagnosis was performed according to the diagnostic criteria of the International Classification of Headache Disorders, Second Edition. All participants underwent physical and neurologic evaluation and completed a detailed headache questionnaire. Results The comparison of 50 patients with NF1 and 50 age‐matched controls revealed that the complaint of headache was significantly more frequent in the NF1 group than in the control group (CG) (62% vs 14%, χ2(1) = 22.4; P < 0.001). Migraine was significantly more frequent in patients with NF1 than in the CG (54% vs 14%, χ2(1) = 17.82; P < 0.001). No differences were found between the two groups regarding the use of simple analgesics (NF1: 14% vs CG: 5%, χ2(1) = 1.18; P = 0.276). Conclusions Children and adolescents with NF1 are prone to migraines. Complaints of headache are very frequent in this population.
AbstractList Despite the high prevalence of headache in patients with neurofibromatosis type 1 (NF1), little data exist regarding the classification and characterization of headaches experienced by these patients. This paper describes a study of headache in patients with NF1 compared with healthy controls. In this transversal study, participants (aged 4-19 years) were classified into two groups: NF1 patients or control subjects. The diagnosis of NF1 was performed according to the diagnostic criteria of the National Institutes of Health Consensus Conference, and the headache diagnosis was performed according to the diagnostic criteria of the International Classification of Headache Disorders, Second Edition. All participants underwent physical and neurologic evaluation and completed a detailed headache questionnaire. The comparison of 50 patients with NF1 and 50 age-matched controls revealed that the complaint of headache was significantly more frequent in the NF1 group than in the control group (CG) (62% vs 14%, χ(2)(1) = 22.4; P < 0.001). Migraine was significantly more frequent in patients with NF1 than in the CG (54% vs 14%, χ(2)(1) = 17.82; P < 0.001). No differences were found between the two groups regarding the use of simple analgesics (NF1: 14% vs CG: 5%, χ(2)(1) = 1.18; P = 0.276). Children and adolescents with NF1 are prone to migraines. Complaints of headache are very frequent in this population.
Background Despite the high prevalence of headache in patients with neurofibromatosis type 1 (NF1), little data exist regarding the classification and characterization of headaches experienced by these patients. This paper describes a study of headache in patients with NF1 compared with healthy controls. Methods In this transversal study, participants (aged 4–19 years) were classified into two groups: NF1 patients or control subjects. The diagnosis of NF1 was performed according to the diagnostic criteria of the National Institutes of Health Consensus Conference, and the headache diagnosis was performed according to the diagnostic criteria of the International Classification of Headache Disorders, Second Edition. All participants underwent physical and neurologic evaluation and completed a detailed headache questionnaire. Results The comparison of 50 patients with NF1 and 50 age‐matched controls revealed that the complaint of headache was significantly more frequent in the NF1 group than in the control group (CG) (62% vs 14%, χ2(1) = 22.4; P < 0.001). Migraine was significantly more frequent in patients with NF1 than in the CG (54% vs 14%, χ2(1) = 17.82; P < 0.001). No differences were found between the two groups regarding the use of simple analgesics (NF1: 14% vs CG: 5%, χ2(1) = 1.18; P = 0.276). Conclusions Children and adolescents with NF1 are prone to migraines. Complaints of headache are very frequent in this population.
Despite the high prevalence of headache in patients with neurofibromatosis type 1 (NF1), little data exist regarding the classification and characterization of headaches experienced by these patients. This paper describes a study of headache in patients with NF1 compared with healthy controls.BACKGROUNDDespite the high prevalence of headache in patients with neurofibromatosis type 1 (NF1), little data exist regarding the classification and characterization of headaches experienced by these patients. This paper describes a study of headache in patients with NF1 compared with healthy controls.In this transversal study, participants (aged 4-19 years) were classified into two groups: NF1 patients or control subjects. The diagnosis of NF1 was performed according to the diagnostic criteria of the National Institutes of Health Consensus Conference, and the headache diagnosis was performed according to the diagnostic criteria of the International Classification of Headache Disorders, Second Edition. All participants underwent physical and neurologic evaluation and completed a detailed headache questionnaire.METHODSIn this transversal study, participants (aged 4-19 years) were classified into two groups: NF1 patients or control subjects. The diagnosis of NF1 was performed according to the diagnostic criteria of the National Institutes of Health Consensus Conference, and the headache diagnosis was performed according to the diagnostic criteria of the International Classification of Headache Disorders, Second Edition. All participants underwent physical and neurologic evaluation and completed a detailed headache questionnaire.The comparison of 50 patients with NF1 and 50 age-matched controls revealed that the complaint of headache was significantly more frequent in the NF1 group than in the control group (CG) (62% vs 14%, χ(2)(1) = 22.4; P < 0.001). Migraine was significantly more frequent in patients with NF1 than in the CG (54% vs 14%, χ(2)(1) = 17.82; P < 0.001). No differences were found between the two groups regarding the use of simple analgesics (NF1: 14% vs CG: 5%, χ(2)(1) = 1.18; P = 0.276).RESULTSThe comparison of 50 patients with NF1 and 50 age-matched controls revealed that the complaint of headache was significantly more frequent in the NF1 group than in the control group (CG) (62% vs 14%, χ(2)(1) = 22.4; P < 0.001). Migraine was significantly more frequent in patients with NF1 than in the CG (54% vs 14%, χ(2)(1) = 17.82; P < 0.001). No differences were found between the two groups regarding the use of simple analgesics (NF1: 14% vs CG: 5%, χ(2)(1) = 1.18; P = 0.276).Children and adolescents with NF1 are prone to migraines. Complaints of headache are very frequent in this population.CONCLUSIONSChildren and adolescents with NF1 are prone to migraines. Complaints of headache are very frequent in this population.
Background Despite the high prevalence of headache in patients with neurofibromatosis type 1 (NF1), little data exist regarding the classification and characterization of headaches experienced by these patients. This paper describes a study of headache in patients with NF1 compared with healthy controls. Methods In this transversal study, participants (aged 4-19 years) were classified into two groups: NF1 patients or control subjects. The diagnosis of NF1 was performed according to the diagnostic criteria of the National Institutes of Health Consensus Conference, and the headache diagnosis was performed according to the diagnostic criteria of the International Classification of Headache Disorders, Second Edition. All participants underwent physical and neurologic evaluation and completed a detailed headache questionnaire. Results The comparison of 50 patients with NF1 and 50 age-matched controls revealed that the complaint of headache was significantly more frequent in the NF1 group than in the control group (CG) (62% vs 14%, χ2(1) = 22.4; P < 0.001). Migraine was significantly more frequent in patients with NF1 than in the CG (54% vs 14%, χ2(1) = 17.82; P < 0.001). No differences were found between the two groups regarding the use of simple analgesics (NF1: 14% vs CG: 5%, χ2(1) = 1.18; P = 0.276). Conclusions Children and adolescents with NF1 are prone to migraines. Complaints of headache are very frequent in this population.
Author Caran, Eliana Maria Monteiro
Masruha, Marcelo Rodrigues
Pinho, Ricardo Silva
Fusão, Eduardo Ferracioli
Paschoal, Joelma Karina Sagica Fernandes
Minett, Thaís Soares Cianciarullo
Vilanova, Luiz Celso Pereira
Author_xml – sequence: 1
  givenname: Ricardo Silva
  surname: Pinho
  fullname: Pinho, Ricardo Silva
  organization: Department of Neurology and Neurosurgery, Federal University of São Paulo, São Paulo, Brazil
– sequence: 2
  givenname: Eduardo Ferracioli
  surname: Fusão
  fullname: Fusão, Eduardo Ferracioli
  organization: Department of Neurology and Neurosurgery, Federal University of São Paulo, São Paulo, Brazil
– sequence: 3
  givenname: Joelma Karina Sagica Fernandes
  surname: Paschoal
  fullname: Paschoal, Joelma Karina Sagica Fernandes
  organization: Department of Neurology and Neurosurgery, Federal University of São Paulo, São Paulo, Brazil
– sequence: 4
  givenname: Eliana Maria Monteiro
  surname: Caran
  fullname: Caran, Eliana Maria Monteiro
  organization: Department of Pediatrics/Pediatric Oncology Institute and Support Group for Children and Adolescents with Cancer, Federal University of São Paulo, São Paulo, Brazil
– sequence: 5
  givenname: Thaís Soares Cianciarullo
  surname: Minett
  fullname: Minett, Thaís Soares Cianciarullo
  organization: Department of Public Health and Primary Care, Cambridge University, Cambridge, UK
– sequence: 6
  givenname: Luiz Celso Pereira
  surname: Vilanova
  fullname: Vilanova, Luiz Celso Pereira
  organization: Department of Neurology and Neurosurgery, Federal University of São Paulo, São Paulo, Brazil
– sequence: 7
  givenname: Marcelo Rodrigues
  surname: Masruha
  fullname: Masruha, Marcelo Rodrigues
  email: mmasruha@ig.com.br
  organization: Department of Neurology and Neurosurgery, Federal University of São Paulo, São Paulo, Brazil
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24832054$$D View this record in MEDLINE/PubMed
BookMark eNp9kU9PFTEUxRuDEXi48AuYJm50MdC_M52lQUAjAiYY3TV9nVspzmufbSfwvj19PmBBIt20SX_n3pNzdtFWiAEQekPJPq3nYAnDPmW8ky_QDhWCNYyQX1v1zZlqFGm7bbSb8zUhRHVKvELbTCjOiBQ76Oyb_52MD4B9xi7B3wlCwT5ge-XHIUHAJgzYDHGEbOtXxje-XOEAU4rOz1NcmBJz1ZbVEjDdQy-dGTO8vr9n6Mfx0eXh5-b0_OTL4cfTxgoqZdNaS7mwvJ_Pe04EOA5WSGOJskw4EL0SLXfDIJ1omXUdJUxRwXoqmey5GfgMvd_MXaZYLeeiF776G0cTIE5Z05b3QrWK84q-e4JexymF6m5NdaIuq9nN0Nt7apovYNDL5BcmrfRDUhX4sAFsijkncI8IJXrdgq4t6H8tVPbgCWt9McXHUGrW43OKGz_C6v-j9cXRpwdFs1H4XOD2UWHSH912a_Ln2Yn-Kr8f80sptOR3acCldg
CitedBy_id crossref_primary_10_3389_fneur_2022_874613
crossref_primary_10_3389_fneur_2023_1213430
crossref_primary_10_1007_s10072_020_04400_x
crossref_primary_10_1002_pbc_30385
crossref_primary_10_1097_j_pain_0000000000001486
crossref_primary_10_1111_ped_13388
crossref_primary_10_1016_j_det_2019_05_015
crossref_primary_10_1007_s11916_022_01032_y
crossref_primary_10_1016_j_phoj_2023_05_002
crossref_primary_10_1002_ajmg_a_37186
crossref_primary_10_1542_peds_2019_0660
crossref_primary_10_3390_cancers15123213
crossref_primary_10_3389_fonc_2024_1323176
Cites_doi 10.1097/GIM.0b013e3181bf15e3
10.1002/ana.23793
10.1111/j.1526-4610.2010.01717.x
10.1177/088307380001500406
10.1097/WCO.0b013e3283378d5c
10.1016/0045-9380(87)90009-0
10.1016/S1474-4422(07)70075-3
10.1126/science.2134734
10.1016/j.ajpath.2010.12.056
10.1046/j.1526-4610.1996.3601010.x
10.1111/ped.12178
10.1111/j.1468-2982.2006.01172.x
ContentType Journal Article
Copyright 2014 Japan Pediatric Society
2014 Japan Pediatric Society.
Pediatrics International © 2014 Japan Pediatric Society
Copyright_xml – notice: 2014 Japan Pediatric Society
– notice: 2014 Japan Pediatric Society.
– notice: Pediatrics International © 2014 Japan Pediatric Society
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7U9
H94
K9.
7X8
DOI 10.1111/ped.12375
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Virology and AIDS Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1442-200X
EndPage 867
ExternalDocumentID 3530104291
24832054
10_1111_ped_12375
PED12375
ark_67375_WNG_K5QF3T54_5
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
  funderid: 2011/50140‐8
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
123
1OB
1OC
29O
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEFGJ
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFEBI
AFFPM
AFGKR
AFRAH
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AHEFC
AHMBA
AIACR
AIDQK
AIDYY
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
EBS
EJD
EMOBN
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WVDHM
WXI
WXSBR
X7M
XG1
YFH
ZZTAW
~IA
~WT
AAHHS
ACCFJ
AEEZP
AEQDE
AEUQT
AFPWT
AIWBW
AJBDE
ESX
WRC
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7U9
H94
K9.
7X8
ID FETCH-LOGICAL-c4155-6cc134c39bb9304ef3ec45ac08c24fe498463fdd5f462cf710281429152593ad3
IEDL.DBID DR2
ISSN 1328-8067
1442-200X
IngestDate Thu Sep 04 16:30:28 EDT 2025
Sat Aug 16 22:11:49 EDT 2025
Mon Jul 21 06:04:02 EDT 2025
Tue Jul 01 03:54:24 EDT 2025
Thu Apr 24 23:06:19 EDT 2025
Wed Jan 22 16:21:10 EST 2025
Sun Sep 21 06:18:21 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords neurofibromatosis type 1
headache
adolescents
children
migraine disorders
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2014 Japan Pediatric Society.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4155-6cc134c39bb9304ef3ec45ac08c24fe498463fdd5f462cf710281429152593ad3
Notes ArticleID:PED12375
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) - No. 2011/50140-8
ark:/67375/WNG-K5QF3T54-5
istex:2DD744BFFC010D98829936BECE8985058E97F5A0
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 24832054
PQID 1637449812
PQPubID 31868
PageCount 3
ParticipantIDs proquest_miscellaneous_1639486833
proquest_journals_1637449812
pubmed_primary_24832054
crossref_primary_10_1111_ped_12375
crossref_citationtrail_10_1111_ped_12375
wiley_primary_10_1111_ped_12375_PED12375
istex_primary_ark_67375_WNG_K5QF3T54_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-12
December 2014
2014-12-00
2014-Dec
20141201
PublicationDateYYYYMMDD 2014-12-01
PublicationDate_xml – month: 12
  year: 2014
  text: 2014-12
PublicationDecade 2010
PublicationPlace Australia
PublicationPlace_xml – name: Australia
– name: Tokyo
PublicationTitle Pediatrics international
PublicationTitleAlternate Pediatr Int
PublicationYear 2014
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References Diggs-Andrews KA, Tokuda K, Izumi Y, Zorumski CF, Wozniak DF, Gutmann DH. Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice. Ann. Neurol. 2013; 73: 309-315.
Clementi M, Battistella PA, Rizzi L, Boni S, Tenconi R. Headache in patients with neurofibromatosis type 1. Headache 1996; 36 (1): 10.
Wallace MR, Marchuk DA, Andersen LB et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 1990; 249 (4965): 181-186.
Bigal ME, Arruda MA. Migraine in the pediatric population - evolving concepts. Headache 2010; 50: 1130-1143.
Dunn DW. Neurofibromatosis in childhood. Curr. Probl. Pediatr. 1987; 17: 445-497.
Charbit AR, Akerman S, Goadsby PJ. Dopamine: what's new in migraine? Curr. Opin. Neurol. 2010; 23: 275-281.
Ferner RE. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol. 2007; 6: 340-351.
DiMario FJ Jr, Langshur S. Headaches in patients with neurofibromatosis-1. J. Child Neurol. 2000; 15: 235-238.
Schorry EK, Stowens DW, Crawford AH, Stowens PA, Schwartz WR, Dignan PS. Summary of patient data from a multidisciplinary neurofibromatosis clinic. Neurofibromatosis 1989; 2: 129-134.
The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24 (Suppl. 1): 9-160.
National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987. Neurofibromatosis 1988; 1: 172-178.
Paschoal JK, Lin J, Pinho RS et al. Psychiatric symptoms may contribute to poor quality of life in adolescents with migraine. Pediatr. Int. 2013; 55: 741-747.
Jouhilahti EM, Peltonen S, Heape AM, Peltonen J. The pathoetiology of neurofibromatosis 1. Am. J. Pathol. 2011; 178: 1932-1939.
Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genet. Med. 2010; 12 (1): 1-11.
Riccardi VM. Neurofibromatosis: Phenotype, Natural History and Pathogenesis. Johns Hopkins University Press, Baltimore, 1986.
Olesen J, Bousser MG, Diener HC et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006; 26: 742-746.
2010; 12
2010; 23
1988; 1
1989; 2
1990; 249
2013; 55
2000; 15
2013; 73
2004; 24
2006; 26
1986
2007; 6
1996; 36
2011; 178
1987; 17
2010; 50
(e_1_2_6_6_1) 1988; 1
Riccardi VM (e_1_2_6_9_1) 1986
Schorry EK (e_1_2_6_10_1) 1989; 2
e_1_2_6_8_1
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_13_1
e_1_2_6_14_1
e_1_2_6_3_1
e_1_2_6_11_1
e_1_2_6_2_1
e_1_2_6_17_1
e_1_2_6_18_1
(e_1_2_6_12_1) 2004; 24
e_1_2_6_15_1
e_1_2_6_16_1
References_xml – reference: The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24 (Suppl. 1): 9-160.
– reference: Wallace MR, Marchuk DA, Andersen LB et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 1990; 249 (4965): 181-186.
– reference: Dunn DW. Neurofibromatosis in childhood. Curr. Probl. Pediatr. 1987; 17: 445-497.
– reference: Schorry EK, Stowens DW, Crawford AH, Stowens PA, Schwartz WR, Dignan PS. Summary of patient data from a multidisciplinary neurofibromatosis clinic. Neurofibromatosis 1989; 2: 129-134.
– reference: DiMario FJ Jr, Langshur S. Headaches in patients with neurofibromatosis-1. J. Child Neurol. 2000; 15: 235-238.
– reference: Charbit AR, Akerman S, Goadsby PJ. Dopamine: what's new in migraine? Curr. Opin. Neurol. 2010; 23: 275-281.
– reference: Riccardi VM. Neurofibromatosis: Phenotype, Natural History and Pathogenesis. Johns Hopkins University Press, Baltimore, 1986.
– reference: National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987. Neurofibromatosis 1988; 1: 172-178.
– reference: Bigal ME, Arruda MA. Migraine in the pediatric population - evolving concepts. Headache 2010; 50: 1130-1143.
– reference: Clementi M, Battistella PA, Rizzi L, Boni S, Tenconi R. Headache in patients with neurofibromatosis type 1. Headache 1996; 36 (1): 10.
– reference: Diggs-Andrews KA, Tokuda K, Izumi Y, Zorumski CF, Wozniak DF, Gutmann DH. Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice. Ann. Neurol. 2013; 73: 309-315.
– reference: Olesen J, Bousser MG, Diener HC et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006; 26: 742-746.
– reference: Ferner RE. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol. 2007; 6: 340-351.
– reference: Jouhilahti EM, Peltonen S, Heape AM, Peltonen J. The pathoetiology of neurofibromatosis 1. Am. J. Pathol. 2011; 178: 1932-1939.
– reference: Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genet. Med. 2010; 12 (1): 1-11.
– reference: Paschoal JK, Lin J, Pinho RS et al. Psychiatric symptoms may contribute to poor quality of life in adolescents with migraine. Pediatr. Int. 2013; 55: 741-747.
– volume: 2
  start-page: 129
  year: 1989
  end-page: 134
  article-title: Summary of patient data from a multidisciplinary neurofibromatosis clinic
  publication-title: Neurofibromatosis
– volume: 249
  start-page: 181
  issue: 4965
  year: 1990
  end-page: 186
  article-title: Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients
  publication-title: Science
– year: 1986
– volume: 1
  start-page: 172
  year: 1988
  end-page: 178
  article-title: National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13–15, 1987
  publication-title: Neurofibromatosis
– volume: 12
  start-page: 1
  issue: 1
  year: 2010
  end-page: 11
  article-title: Clinical and genetic aspects of neurofibromatosis 1
  publication-title: Genet. Med.
– volume: 55
  start-page: 741
  year: 2013
  end-page: 747
  article-title: Psychiatric symptoms may contribute to poor quality of life in adolescents with migraine
  publication-title: Pediatr. Int.
– volume: 36
  start-page: 10
  issue: 1
  year: 1996
  article-title: Headache in patients with neurofibromatosis type 1
  publication-title: Headache
– volume: 17
  start-page: 445
  year: 1987
  end-page: 497
  article-title: Neurofibromatosis in childhood
  publication-title: Curr. Probl. Pediatr.
– volume: 73
  start-page: 309
  year: 2013
  end-page: 315
  article-title: Dopamine deficiency underlies learning deficits in neurofibromatosis‐1 mice
  publication-title: Ann. Neurol.
– volume: 178
  start-page: 1932
  year: 2011
  end-page: 1939
  article-title: The pathoetiology of neurofibromatosis 1
  publication-title: Am. J. Pathol.
– volume: 23
  start-page: 275
  year: 2010
  end-page: 281
  article-title: Dopamine: what's new in migraine?
  publication-title: Curr. Opin. Neurol.
– volume: 6
  start-page: 340
  year: 2007
  end-page: 351
  article-title: Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective
  publication-title: Lancet Neurol.
– volume: 24
  start-page: 9
  issue: Suppl. 1
  year: 2004
  end-page: 160
  article-title: The International Classification of Headache Disorders: 2nd edition
  publication-title: Cephalalgia
– volume: 26
  start-page: 742
  year: 2006
  end-page: 746
  article-title: New appendix criteria open for a broader concept of chronic migraine
  publication-title: Cephalalgia
– volume: 15
  start-page: 235
  year: 2000
  end-page: 238
  article-title: Headaches in patients with neurofibromatosis‐1
  publication-title: J. Child Neurol.
– volume: 50
  start-page: 1130
  year: 2010
  end-page: 1143
  article-title: Migraine in the pediatric population – evolving concepts
  publication-title: Headache
– volume: 2
  start-page: 129
  year: 1989
  ident: e_1_2_6_10_1
  article-title: Summary of patient data from a multidisciplinary neurofibromatosis clinic
  publication-title: Neurofibromatosis
– ident: e_1_2_6_7_1
  doi: 10.1097/GIM.0b013e3181bf15e3
– ident: e_1_2_6_17_1
  doi: 10.1002/ana.23793
– ident: e_1_2_6_15_1
  doi: 10.1111/j.1526-4610.2010.01717.x
– ident: e_1_2_6_11_1
  doi: 10.1177/088307380001500406
– ident: e_1_2_6_16_1
  doi: 10.1097/WCO.0b013e3283378d5c
– ident: e_1_2_6_14_1
  doi: 10.1016/0045-9380(87)90009-0
– volume-title: Neurofibromatosis: Phenotype, Natural History and Pathogenesis
  year: 1986
  ident: e_1_2_6_9_1
– ident: e_1_2_6_2_1
  doi: 10.1016/S1474-4422(07)70075-3
– ident: e_1_2_6_4_1
  doi: 10.1126/science.2134734
– ident: e_1_2_6_5_1
  doi: 10.1016/j.ajpath.2010.12.056
– volume: 1
  start-page: 172
  year: 1988
  ident: e_1_2_6_6_1
  article-title: National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13–15, 1987
  publication-title: Neurofibromatosis
– ident: e_1_2_6_8_1
  doi: 10.1016/0045-9380(87)90009-0
– ident: e_1_2_6_3_1
  doi: 10.1046/j.1526-4610.1996.3601010.x
– volume: 24
  start-page: 9
  issue: 1
  year: 2004
  ident: e_1_2_6_12_1
  article-title: The International Classification of Headache Disorders: 2nd edition
  publication-title: Cephalalgia
– ident: e_1_2_6_18_1
  doi: 10.1111/ped.12178
– ident: e_1_2_6_13_1
  doi: 10.1111/j.1468-2982.2006.01172.x
SSID ssj0008784
Score 2.1088471
Snippet Background Despite the high prevalence of headache in patients with neurofibromatosis type 1 (NF1), little data exist regarding the classification and...
Despite the high prevalence of headache in patients with neurofibromatosis type 1 (NF1), little data exist regarding the classification and characterization of...
Background Despite the high prevalence of headache in patients with neurofibromatosis type 1 (NF1), little data exist regarding the classification and...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 865
SubjectTerms Adolescent
adolescents
Case-Control Studies
Child
Child, Preschool
children
Female
Genetic disorders
headache
Headaches
Humans
Male
Medical research
Migraine
migraine disorders
Migraine Disorders - diagnosis
Migraine Disorders - epidemiology
Neurofibromatosis 1 - complications
Neurofibromatosis 1 - diagnosis
neurofibromatosis type 1
Neurological disorders
Pediatrics
Prevalence
Title Migraine is frequent in children and adolescents with neurofibromatosis type 1
URI https://api.istex.fr/ark:/67375/WNG-K5QF3T54-5/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fped.12375
https://www.ncbi.nlm.nih.gov/pubmed/24832054
https://www.proquest.com/docview/1637449812
https://www.proquest.com/docview/1639486833
Volume 56
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 1328-8067
  databaseCode: DR2
  dateStart: 19970101
  customDbUrl:
  isFulltext: true
  eissn: 1442-200X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0008784
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3daxQxEB9KBfHF-u3VKlFEfNljdzPZZOmTaM-i3KHSYh-EkM0mcrTslfuA4l_fSfbDViqIbws7YZNMZvLbyeQ3AK-NRI_cuCQVqUkQc5-UZZ4lJkQgZeFVbUMccjorDo_x04k42YL9_i5Myw8xBNyCZUR_HQzcVKsrRn7u6jG5XRkumGdcxCPab7-po5RUbUHbXJEXLmTHKhSyeIaW1_aiW2FaL24Cmtdxa9x4Jjvwo-9ym29yOt6sq7H99Qeb43-O6R7c7QApe9euoPuw5ZoHcHvaHbk_hNl0_jOUkXBsvmJ-GTOv12zesP4aODNNza4QQ7EQ2mWRJ9NTZxYEiRcrahuCvSx7BMeTg6P3h0lXhCGxAWskhbUZR8vLqip5is5zZ1EYmyqbo3dYEoDhvq6FxyK3PgKWjDa5UFep5Kbmj2G7WTTuKTCh6jSrhPUZSrSpp5-nSkpZKpcags12BG97dWjbMZSHQhlnuv9TofnRcX5G8GoQPW9pOW4SehN1OkiY5WnIY5NCf5991J_F1wk_EqhJcK9Xuu5MeKUJqEqk4WX5CF4Or8n4womKadxiE2VKVIXifARP2sUyfCxHcpYEiGlUUeV_76f-cvAhPuz-u-gzuEPQDdvEmj3YXi837jnBo3X1ItrBJa1rB8M
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3daxQxEB9qC-qL3x-nVaOI-LLH7may2QVfxPY8be9QuWJfSshmEzkqe-U-QPzrnWQ_bKWC-LawEzbJZCa_nUx-A_BSS3TItY1iEesIMXVRUaRJpH0EUmYur4yPQ06m2fgIPx6L4y14092Fafgh-oCbt4zgr72B-4D0OSs_s9WQ_K4UV2DHn895s9z78ps8Kpd5U9I2zckPZ7LlFfJ5PH3TC7vRjp_YH5dBzYvINWw9o5tw0nW6yTg5HW7W5dD8_IPP8X9HdQtutJiUvW0W0W3YsvUduDppT93vwnQy_-YrSVg2XzG3DMnXazavWXcTnOm6Yue4oZiP7rJAlemoNwtCxYsVtfXxXpbcg6PR_uzdOGrrMETGw40oMybhaHhRlgWP0TpuDQpt4tyk6CwWhGG4qyrhMEuNC5gloX3Ol1YquK74fdiuF7V9CEzkVZyUwrgEJZrY0f9TKaUschtrQs5mAK87fSjTkpT7WhnfVfezQvOjwvwM4EUvetYwc1wm9CootZfQy1OfyiaF-jp9rw7E5xGfCVQkuNtpXbVWvFKEVSXS8JJ0AM_712R__lBF13axCTIF5lnO-QAeNKul_1iK5C8JE9Oogs7_3k_1aX8vPDz6d9FncG08mxyqww_Tg8dwnZAcNnk2u7C9Xm7sE0JL6_JpMIpfJ4wL3w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3daxQxEB9qC8UXvz-uVo0i4sseu5vJZhefxPas1juqtNiHQshmEzla9o77APGvd5L9sJUK4tvCTtgkszP5ZTL5DcArLdEh1zaKRawjxNRFRZEmkfYRSJm5vDI-DjmeZAcn-OlUnG7A2-4uTMMP0QfcvGUEf-0NfF65S0Y-t9WQ3K4UN2ALM9pdeUT09Td3VC7zpqJtmpMbzmRLK-TTePqmVxajLT-vP65DmleBa1h5RrfhrOtzk3ByPlyvyqH5-Qed438O6g7cahEpe9f8Qndhw9b3YHvcnrnfh8l4-t3XkbBsumRuEVKvV2xas-4eONN1xS4xQzEf22WBKNNRZ2aEiWdLauujvSx5ACej_eP3B1FbhSEyHmxEmTEJR8OLsix4jNZxa1BoE-cmRWexIATDXVUJh1lqXEAsCa1yvrBSwXXFH8JmPavtY2Air-KkFMYlKNHEjnZPpZSyyG2sCTebAbzp1KFMS1HuK2VcqG6rQvOjwvwM4GUvOm94Oa4Teh102kvoxblPZJNCfZt8UIfiy4gfC1QkuNspXbU2vFSEVCXS8JJ0AC_612R9_khF13a2DjIF5lnO-QAeNT9L_7EUyVsSIqZRBZX_vZ_qaH8vPOz8u-hz2D7aG6nPHyeHT-AmwThskmx2YXO1WNunBJVW5bNgEr8A9-oKjg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Migraine+is+frequent+in+children+and+adolescents+with+neurofibromatosis+type+1&rft.jtitle=Pediatrics+international&rft.au=Pinho%2C+Ricardo+Silva&rft.au=Fus%C3%A3o%2C+Eduardo+Ferracioli&rft.au=Paschoal%2C+Joelma+Karina+Sagica+Fernandes&rft.au=Caran%2C+Eliana+Maria+Monteiro&rft.date=2014-12-01&rft.issn=1328-8067&rft.eissn=1442-200X&rft.volume=56&rft.issue=6&rft.spage=865&rft.epage=867&rft_id=info:doi/10.1111%2Fped.12375&rft.externalDBID=10.1111%252Fped.12375&rft.externalDocID=PED12375
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1328-8067&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1328-8067&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1328-8067&client=summon